Skip to main content

Analysis of (1→3) β-d-glucan as a diagnostic adjunct for invasive fungal infections in the ICU setting

Introduction

Since invasive fungal infections are associated with high morbidity and increased mortality in the ICU, early diagnosis and treatment are essential. This study assesses the performance of an assay of serum (1→3)-D-glucan (BDG) concentration in patients admitted to the ICU.

Methods

Patients admitted to our advanced critical care center from April 2007 to March 2011 with measurements of BDG were enrolled in this retrospective study. BDG was measured when invasive fungal infection was suspected based on the Japanese guidelines for diagnosis and treatment of invasive fungal infections. BDG levels were measured using the WAKO method. A BDG level greater than 11 pg/ml was considered to be positive. No gray zone was considered.

Results

Of the 872 patients enrolled in this study, there were 580 males and 292 females. The mean age was 60.7 years (range: 48 to 87). The mortality rate was 16.3%. We make a clinical diagnosis of invasive fungal infections according to Japanese guidelines for diagnosis and treatment of invasive fungal infections. The sensitivity of the BDG assay was 71.9% and the specificity was 91.0%. There were significant differences in sensitivity, specificity, and optimal cut-off points among patients with different clinical conditions (that is, trauma, burn, postoperative, and medical conditions).The area under the summary receiver operating characteristic curve was 0.82, but there were also differences across clinical categories.

Conclusion

The BDG profile in ICU patients is similar to that of other inpatients. It can be useful in clinical practice if implemented in the proper setting and interpreted after consideration of the patient's clinical status.

References

  1. 1.

    Committee for Guideline for Management of Deep-seated Mycoses 2007: Guideline for Management of Deep-seated Mycoses 2007. Tokyo: Kyowa kikaku; 2007.

    Google Scholar 

  2. 2.

    Drosos EK, et al.: β-D-glucan assay for the diagnosis of invasive fungal infections: a meta analysis. Clin Infect Dis 2011, 52: 750-770. 10.1093/cid/ciq206

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to N Yamada.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Yamada, N., Shirai, K., Doi, T. et al. Analysis of (1→3) β-d-glucan as a diagnostic adjunct for invasive fungal infections in the ICU setting. Crit Care 16, P36 (2012). https://doi.org/10.1186/cc10643

Download citation

Keywords

  • Emergency Medicine
  • Critical Care
  • Care Center
  • Characteristic Curve
  • High Morbidity